CC
RBOT

Centiva Capital’s Vicarious Surgical RBOT Stock Holding History

Centiva Capital’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,077
Closed -$321K – 1587
2021
Q1 		$321K Sell
1,077
-256
-19% -$78.3K 0.01% 732
2020
Q4 		$406K Buy
1,333
+666
+100% +$196K 0.02% 538
2020
Q3 		$195K Buy
+667
New +$196K 0.01% 609

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $54B AUM 23.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Centiva Capital's RBOT Position: Q2 2021 in Review

Centiva Capital sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 1,077 shares — an estimated $321K sold.

Centiva Capital first reported a position in RBOT in Q3 2020 and held it in 3 quarters. The position peaked at $406K in Q4 2020. 99 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Centiva Capital reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 1,077 Vicarious Surgical shares in Q2 2021, an estimated $321K.
  • Centiva Capital first reported a position in Vicarious Surgical in Q3 2020 and held it in 3 quarters.
  • Centiva Capital's Vicarious Surgical position peaked at $406K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.